Literature DB >> 8935817

Does eosinophilia predict clozapine induced neutropenia?

M Hummer1, B Sperner-Unterweger, G Kemmler, M Falk, M Kurz, H Oberbauer, W W Fleischhacker.   

Abstract

The atypical antipsychotic clozapine carries a high risk of inducing agranulocytosis. We attempted to investigate whether eosinophilia during clozapine treatment has predictive value for subsequent neutropenia/agranulocytosis. One hundred and seventy-seven patients were studied in a prospective naturalistic design using haloperidol as the reference compound. Clozapine was found to differ from haloperidol in respect to their influence on neutrophil granulocytes. In the clozapine group patients with eosinophilia showed a decrease in neutrophil count (less than 2000/mm3 neutrophil granulocytes) significantly more often than patients without eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8935817     DOI: 10.1007/bf02245622

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Eosinophilia, clozapine, and pancreatitis.

Authors:  F R Frankenburg; J Kando
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

2.  Major histocompatibility complex associations with clozapine-induced agranulocytosis. The USA experience.

Authors:  J J Yunis; J Lieberman; E J Yunis
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

3.  Eosinophilia with clozapine.

Authors:  B H Stricker; J A Tielens
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

Review 4.  [GM-CSF and G-CSF: cytokines in clinical application].

Authors:  C Ruef; D L Coleman
Journal:  Schweiz Med Wochenschr       Date:  1991-03-23

5.  Clozapine-induced transient white blood count disorders.

Authors:  M Hummer; M Kurz; C Barnas; A Saria; W W Fleischhacker
Journal:  J Clin Psychiatry       Date:  1994-10       Impact factor: 4.384

6.  Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis.

Authors:  A V Pisciotta; S A Konings; L L Ciesemier; C E Cronkite; J A Lieberman
Journal:  J Lab Clin Med       Date:  1992-03

7.  High risk of eosinophilia in women treated with clozapine.

Authors:  M D Banov; M Tohen; J Friedberg
Journal:  J Clin Psychiatry       Date:  1993-12       Impact factor: 4.384

8.  No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis.

Authors:  F H Claas; P A Abbott; M D Witvliet; J D'Amaro; P M Barnes; P Krupp
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

Review 9.  On the possible mechanisms and predictability of clozapine-induced agranulocytosis.

Authors:  A V Pisciotta; S A Konings; L L Ciesemier; C E Cronkite; J A Lieberman
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

Review 10.  Clozapine-associated agranulocytosis: risk and aetiology.

Authors:  P Krupp; P Barnes
Journal:  Br J Psychiatry Suppl       Date:  1992-05
View more
  4 in total

Review 1.  Clozapine versus typical neuroleptic medication for schizophrenia.

Authors:  Adib Essali; Nahla Al-Haj Haasan; Chunbo Li; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

2.  Clozapine induced eosinophilia.

Authors:  Pradipta Majumder; R K Chadda; P Goyal; A Mittal; Nand Kumar
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

3.  Eosinophilia induced by clozapine: a report of two cases and review of the literature.

Authors:  Jitender Aneja; Nidhi Sharma; Sudhir Mahajan; Subho Chakrabarti; Sandeep Grover
Journal:  J Family Med Prim Care       Date:  2015 Jan-Mar

4.  Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.

Authors:  Aakanksha Singh; Sandeep Grover; Pankaj Malhotra; Subhash C Varma
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.